Development of antibody-based c-Met inhibitors for targeted cancer therapy

Development of antibody-based c-Met inhibitors for targeted cancer therapy

Dongheon Lee, Eun-Sil Sung, Jin-Hyung Ahn, Sungwon An, Jiwon Huh, Weon-Kyoo You Hanwha Chemical R&D Center, Biologics Business Unit, Daejeon, Republic of Korea Abstract: Signaling pathways mediated by receptor tyrosine kinases (RTKs) and their ligands play important roles in the development...

Full description

Bibliographic Details
Main Authors: Lee D, Sung ES, Ahn JH, An S, Huh J, You WK
Format: Article
Language:English
Published: Dove Medical Press 2015-02-01
Series:ImmunoTargets and Therapy
Subjects:
Hepatocyte growth factor
Ligands
Receptor tyrosine kinase
Signaling pathway
Therapeutic agent
Online Access:https://www.dovepress.com/development-of-antibody-based-c-met-inhibitors-for-targeted-cancer-the-peer-reviewed-article-ITT

Internet

https://www.dovepress.com/development-of-antibody-based-c-met-inhibitors-for-targeted-cancer-the-peer-reviewed-article-ITT

Similar Items